Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression

NCT03598868 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT03598868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03598868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar Depression
Lead sponsor
Seoul National University Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 8, 2018
Completion date
September 25, 2021
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder depression